CORD-19:8c51cf0cc444f6a851ad178040369984759ddfec / 17784-17891 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T143","span":{"begin":0,"end":107},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Ninety percent (27 of 30) of RP patients with macular edema contained antiretinal antibodies in their sera."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T143","span":{"begin":0,"end":107},"obj":"Sentence"}],"text":"Ninety percent (27 of 30) of RP patients with macular edema contained antiretinal antibodies in their sera."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T70","span":{"begin":29,"end":31},"obj":"Phenotype"},{"id":"T71","span":{"begin":46,"end":59},"obj":"Phenotype"}],"attributes":[{"id":"A70","pred":"hp_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/HP_0000510"},{"id":"A71","pred":"hp_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/HP_0040049"}],"text":"Ninety percent (27 of 30) of RP patients with macular edema contained antiretinal antibodies in their sera."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T148","span":{"begin":29,"end":31},"obj":"Disease"},{"id":"T149","span":{"begin":46,"end":59},"obj":"Disease"},{"id":"T86437","span":{"begin":29,"end":31},"obj":"Disease"},{"id":"T21622","span":{"begin":46,"end":59},"obj":"Disease"}],"attributes":[{"id":"A148","pred":"mondo_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/MONDO_0008377"},{"id":"A149","pred":"mondo_id","subj":"T149","obj":"http://purl.obolibrary.org/obo/MONDO_0003005"},{"id":"A43620","pred":"mondo_id","subj":"T86437","obj":"http://purl.obolibrary.org/obo/MONDO_0008377"},{"id":"A65512","pred":"mondo_id","subj":"T21622","obj":"http://purl.obolibrary.org/obo/MONDO_0003005"}],"text":"Ninety percent (27 of 30) of RP patients with macular edema contained antiretinal antibodies in their sera."}